OUR TEAM

Patrick Vollmer, OD, FAAO

Dr. Patrick Vollmer is an award-winning author, international speaker, and clinical researcher for novel developments in ophthalmic drugs. He specializes in comprehensive eye exams, contact lenses, eye emergencies/eye trauma and ocular disease. Dr. Vollmer holds a particular interest in diagnosing and customizing individual treatment plans for dry eye. Dr. Vollmer currently splits his time 50/50 with clinical patients and research patients.

He is passionate about emergency ocular medicine, ophthalmic diseases, diabetic and hypertensive eye disease, glaucoma, co-management of systemic diseases, and updates in pharmacology and pharmacokinetics. In order to take the very best care of your eyes, the clinic is equipped with the most cutting edge medical technologies found in the industry to date.

Originally from Blowing Rock, NC, Dr. Vollmer now lives locally in Shelby with his fiancé (Anna) and two dogs (Bentley + Ellie), who are widely recognized and entertain all patients who enter the clinic doors.

Awards
  • Top-300 Innovators in Optometry- Primary Care Optometry News, Healio
  • Top 50 Up-and-Coming Practitioners/Researchers in the United States- Primary Care Optometry News, Healio
  • Best Optometrist in Cleveland County- Winner: 2020
  • Best Optometrist in Cleveland County- Winner: 2019
  • Best Optometrist in Cleveland County- Winner: 2018
  • Best Optometrist in Cleveland County- Winner: 2017
  • Best Optometrist in Cleveland County- Winner: 2016

Background
  • Undergraduate- Appalachian State University, Boone, NC
  • Doctorate- Indiana University, Bloomington, IN
  • Internship- Charlotte Eye, Ear, Nose and Throat Associates, Charlotte, NC 
  • Residency- (Hospital) William Jennings Bryan Dorn VA Medical Center, Columbia, SC
  • Post-Doctoral- Stanford Graduate School of Business, Executive Education
Clinical Research
  • DESign 19: Ophthalmic Assessments of Signs and Symptoms of Dry Eye in Patients Suffering from Self-Reported or Clinician-Diagnosed Dry Eye Disease
  • DESign 20: Ophthalmic Assessments of Signs and Symptoms of Dry Eye in Patients Suffering from Self-Reported or Clinician-Diagnosed Dry Eye Disease
  • Evaluation of Eyelashes and Lid Margins in Patients with Blepharitis 
  • CYSign2020: Ophthalmic Assessments of Signs and Symptoms of Dry Eye in Patients Suffering from Self-Reported or Clinician-Diagnosed Dry Eye Disease
  • VISTA-2: Ophthalmic Assessments of Signs and Symptoms of Dry Eye in Patients Suffering from Self-Reported or Clinician-Diagnosed Dry Eye Disease
  • Evaluation of Eyelashes and Lid Margins in Patients with Blepharitis 
  • A Phase 3, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of SkQ1 Ophthalmic Solution in the Environment and During Challenge in the Controlled Adverse Environmental (CAE) Model for the Treatment of Dry Eye Syndrome 
  • The RENEW Trial: A Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Adaptive Phase 3 Clinical Trial to Assess the Safety and Efficacy of Reproxalap 0.25% Ophthalmic Solution Compared to Vehicle in Subjects with Dry Eye Disease
  • A Phase 3, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study Evaluating the Efficacy and Safety of 0.25% HL036 Ophthalmic Solution Compared to Placebo in Subjects with Dry Eye
  • A Multi-Center, Double-Masked, Randomized, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of Dupilumab in Patients with Atopic Keratoconjunctivitis (AKC) 
  • A Multi-Centered, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solutions for the Treatment of Dry Eye Using the Controlled Adverse Environmental (CAE) Model (ARISE-3)
  • A Phase 3, Multi-Center, Randomized, Controlled, Double-Masked, Clinical Trial to Evaluate the Efficacy and Safety of OC-01 (varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease (The ONSET-2 Study)
  • A Phase 3, Multi-Center, Randomized, Double-Masked, Vehicle-Controlled Clinical Study to Assess the Safety and Efficacy of 1% Tavilermide and 5% Tavilermide Ophthalmic Solutions for the Treatment of Dry Eye
  • Mallinckrodt: A Multi-Center, Open-Label Study to Assess the Efficacy and Safety of Acthar Gel in Subjects with Severe Keratitis 
  • Randomized, Controlled, Multicenter, Double-Masked, Parallel, Phase 2b/3 Trial to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis (Saturn-1)
  • A Phase 2b, Multi-Center, Randomized, Double-Masked, Vehicle-Controlled Clinical Study to Evaluate the Safety and Efficacy of AR-15512 Ophthalmic Solution for the Treatment of Dry Eye Disease Using the Controlled Adverse Environmental CAE Model (COMET-1)
  • The TRANQUILITY Trial: A Multi-Center Randomized, Double-Masked, Parallel Design, Vehicle-Controlled Phase 2/3 Clinical Trial to Assess the Efficacy and Safety of 0.25% Reproxalap Ophthalmic Solution Compared to Vehicle in Subjects with Dry Eye Disease
  • A Multi-Center, Randomized, Double-Masked, Placebo-Controlled, Phase 2b Study Evaluating the Safety and Efficacy of NCX 4251 (Fluticasone Propionate Nanocrystal) Ophthalmic Suspension, 0.1% QD for the Treatment of Acute Exacerbations of Blepharitis (Mississippi) 
  • A Phase 3, Multi-Center, Randomized, Double-Masked, Vehicle-Controlled Clinical Trial to Assess the Efficacy and Safety of Topical CyclASol for the Treatment of Dry Eye Disease
Publications/Posters
  • Review of Optometry: 2019 Clinical Guide to Ophthalmic Drugs
  • Review of Optometry: 2018 Clinical Guide to Ophthalmic Drugs
  • Review of Optometry: 2017 Clinical Guide to Ophthalmic Drugs
  • Melton, Thomas, and Vollmer’s 21st Century Perspective on Glaucoma Patient Care
  • Chronic Myeloid Leukemic Infiltrative Retinopathy, AAOPT, October 2015
  • Non-Hodgkin’s Lymphoma Metastasis to the Right Lateral Rectus, SECO, February 2016
  • Optic Neuritis as an Initial Presentation in the Setting of Multiple Sclerosis, SCO, June 2016
  • Herpes Zoster Ophthalmicus, October 2016

Affiliations
  • Fellow of the American Academy of Optometry (FAAO)
  • American Optometric Association (AOA)
  • North Carolina Optometric Society (NCOS)
  • Uptown Shelby Association Board of Directors 
  • Cleveland County Rotary Club Member
  • Business Network International (Shelby)